Medpace Holdings Is Maintained at Neutral by Baird
Medpace Hldgs Analyst Ratings
Baird Maintains Medpace(MEDP.US) With Hold Rating, Raises Target Price to $354
Truist Financial Maintains Medpace(MEDP.US) With Hold Rating, Announces Target Price $347
TD Cowen Maintains Medpace(MEDP.US) With Buy Rating, Maintains Target Price $372
Medpace Holdings Is Maintained at Buy by TD Cowen
TD Cowen Maintains Buy on Medpace Hldgs, Lowers Price Target to $372
Medpace Holdings Cut to Neutral From Outperform by Baird
Baird Downgrades Medpace(MEDP.US) to Hold Rating, Cuts Target Price to $349
Medpace Hldgs Analyst Ratings
Analysts Are Bullish on Top Healthcare Stocks: Medpace Holdings (MEDP), Veeva Systems (VEEV)
Truist Financial Maintains Medpace(MEDP.US) With Hold Rating
TD Cowen Maintains Medpace(MEDP.US) With Buy Rating, Cuts Target Price to $372
Analysts Conflicted on These Healthcare Names: Medpace Holdings (MEDP), McKesson (MCK) and Glaukos (GKOS)
Medpace Holdings Is Maintained at Hold by Truist Securities
Medpace Hldgs Analyst Ratings
Redburn Atlantic Initiates Medpace Holdings at Buy With $404 Price Target
Truist Financial Maintains Medpace(MEDP.US) With Hold Rating, Cuts Target Price to $397
UBS Downgrades Medpace(MEDP.US) to Hold Rating, Cuts Target Price to $350
Maintaining Hold on Medpace Holdings Amid Market Headwinds and Revised Growth Expectations